Versant Vantage I GP-GP, LLC, 10% Owner at LAVA Therapeutics NV (LVTX), sold 3,368,868 shares at $1.49 ($5.0M) on 2025-09-17, disclosed to the SEC on 2025-09-18.
Open-market sale of $5.0M LVTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.53 | 192,293 | $294K | 5.9% |
| 2 | $1.53 | 192,293 | $294K | 5.9% |
| 3 | $1.53 | 307,707 | $471K | 9.4% |
| 4 | $1.53 | 307,707 | $471K | 9.4% |
| 5 | $1.49 | 226,726 | $338K | 6.8% |
| 6 | $1.49 | 226,726 |
| $338K |
| 6.8% |
| 7 | $1.49 | 362,806 | $541K | 10.8% |
| 8 | $1.49 | 362,806 | $541K | 10.8% |
| 9 | $1.44 | 228,791 | $329K | 6.6% |
| 10 | $1.44 | 228,791 | $329K | 6.6% |
| 11 | $1.44 | 366,111 | $527K | 10.5% |
| 12 | $1.44 | 366,111 | $527K | 10.5% |
| Total | $1.48 avg | 3,368,868 | $5.0M | 100% |